Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper-Reference-Cited by-同舟云学术

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

Published:2019-08 Issue:8 Volume:9 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Barbui Tiziano,De Stefano Valerio^ORCID,Falanga Anna^ORCID,Finazzi Guido,Martinelli Ida,Rodeghiero Francesco,Vannucchi Alessandro M.,Barosi Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-019-0225-5.pdf

Reference116 articles.

1. Rampal, R. & Levine, R. L. A primer on genomic and epigenomic alterations in the myeloproliferative neoplasms. Best Pract. Res. Clin. Haematol. 27, 83–93 (2014).

2. Barbui, T., Finazzi, G. & Falanga, A. Myeloproliferative neoplasms and thrombosis. Blood 122, 2176–2084 (2013).

3. Barbui, T. et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 120, 5128–5133 (2012).

4. Barbui, T. et al. Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in polycythemia vera. Blood Cancer J. 8, 124 (2018).

5. De Stefano, V. et al. Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases. Blood Cancer J. 8, 112 (2018).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation for Budd-Chiari Syndrome From Myeloproliferative Neoplasms - Management and Long-Term Results;Transplantation Proceedings;2024-09

2. Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms;Blood Advances;2024-08-14

3. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study;American Journal of Clinical Pathology;2024-04-10

4. The Effect of Individual Compounds from <i>Rubus chamaemoruson</i> Hemostasis <i>in vitro</i>;Drug development & registration;2024-02-12

5. Evaluating of Existing VTE Risk Scales in Glioma Patients;Clinical and Applied Thrombosis/Hemostasis;2024-01